☆ 4.7 Letter

Infection risk associated with clonal hematopoiesis of indeterminate potential is partly mediated by hematologic cancer transformation in the UK Biobank

LEUKEMIA (2023)

期刊

LEUKEMIA

卷 -, 期 -, 页码 -

出版社

SPRINGERNATURE

DOI: 10.1038/s41375-023-02023-7

关键词

-

类别

Oncology Hematology

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Review Hematology

Hematopoiesis of Indeterminate Potential and Atherothrombotic Risk

Andrew J. Murphy, Dragana Dragoljevic, Pradeep Natarajan, Nan Wang

Summary: Hematopoiesis is the process of blood production, but the susceptibility of hematopoietic stem cells to mutations can lead to clonal hematopoietic disorders. Clonal hematopoiesis is associated with aging, where mutant stem cells produce a small portion of mature immune cells. People with clonal hematopoiesis have an increased risk of mortality due to cardiovascular disease.

THROMBOSIS AND HAEMOSTASIS (2022)

添加到收藏夹

Article Cell Biology

Association of Clonal Hematopoiesis of Indeterminate Potential with Inflammatory Gene Expression in Patients with COPD

Stefan Kuhnert, Siavash Mansouri, Michael A. Rieger, Rajkumar Savai, Edibe Avci, Gabriela Diaz-Pina, Manju Padmasekar, Mario Looso, Stefan Hadzic, Till Acker, Stephan Klatt, Jochen Wilhelm, Ingrid Fleming, Natascha Sommer, Norbert Weissmann, Claus Vogelmeier, Robert Bals, Andreas Zeiher, Stefanie Dimmeler, Werner Seeger, Soni S. Pullamsetti

Summary: This study found an increased incidence of CHIP mutations in COPD patients, which are associated with hypomethylation of PLD5, leading to elevated levels of glycerol phosphocholine, pro-inflammatory cytokines, and deteriorating lung function.

CELLS (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Telomere Attrition and Clonal Hematopoiesis of Indeterminate Potential in Cardiovascular Disease

Yi-Chun Huang, Chao-Yung Wang

Summary: Recent studies have highlighted the important roles of telomere, CHIP, and atherosclerosis in cardiovascular disease. Telomere attrition is associated with CHIP, commonly observed in elderly patients. Telomeres, CHIP, and atherosclerosis contribute to chronic inflammation and proinflammatory cytokine expression.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

添加到收藏夹

Article Oncology

Associations between Ambient Air Pollutants and Clonal Hematopoiesis of Indeterminate Potential

Claire L. Leiser, Eric A. Whitsel, Alexander Reiner, Stephen S. Rich, Jerome I. Rotter, Kent D. Taylor, Russel P. Tracy, Charles Kooperberg, Albert Vernon Smith, JoAnn E. Manson, Josyf C. Mychaleckyj, Alexander G. Bick, Adam A. Szpiro, Joel D. Kaufman

Summary: This study aimed to estimate the association between air pollution and clonal hematopoiesis of indeterminate potential (CHIP). The results showed no evidence of an association between air pollution and CHIP prevalence in two large observational cohorts.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2023)

添加到收藏夹

Article Clinical Neurology

Prevalence and Therapeutic Implications of Clonal Hematopoiesis of Indeterminate Potential in Young Patients With Stroke

Ernst Mayerhofer, Christoph Strecker, Heiko Becker, Marios K. Georgakis, Md Mesbah Uddin, Michael M. Hoffmann, Niroshan Nadarajah, Manja Meggendorfer, Torsten Haferlach, Jonathan Rosand, Pradeep Natarajan, Christopher D. Anderson, Andreas Harloff, Gregor Hoermann

Summary: Genetic screening in young stroke patients revealed a 3-fold higher prevalence of clonal hematopoiesis compared to the general population. About 4.4% of patients had high-risk clonal hematopoiesis and 1% had covert myeloproliferative neoplasms, requiring specific treatment. These findings highlight the diagnostic and therapeutic value of genetic screening in young stroke patients.

STROKE (2023)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Clonal Hematopoiesis of Indeterminate Potential From a Heart Failure Specialist's Point of View

Maurits A. Sikking, Sophie L. V. M. Stroeks, Olivia J. Waring, Michiel T. H. M. Henkens, Niels P. Riksen, Alexander Hoischen, Stephane R. B. Heymans, Job A. J. Verdonschot

Summary: Clonal hematopoiesis of indeterminate potential (CHIP) is a common bone marrow abnormality caused by age-related DNA mutations, which leads to the production of proinflammatory immune cells. These immune cells aggravate atherosclerotic cardiovascular disease and may contribute to heart failure. The mechanisms involved suggest that proinflammatory macrophages and an inflammasome-dependent immune response play a central role. Intracardiac inflammation can decrease cardiac function and induce cardiac fibrosis, even without the presence of atherosclerotic cardiovascular disease. The pathophysiology and consequences of CHIP can vary depending on the implicated genes and subgroups of heart failure patients.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

Serum biomarkers are altered in UK Biobank participants with mosaic chromosomal alterations

Aubrey K. Hubbard, Derek W. Brown, Weiyin Zhou, Shu-Hong Lin, Giulio Genovese, Stephen J. Chanock, Mitchell J. Machiela

Summary: Age-related clonal expansion of cells with chromosomal alterations is an important aspect of clonal haematopoiesis. This study investigated the association between widely measured serum biomarkers and clonal expansion of cells with chromosomal alterations, providing new insights into the molecular changes that promote acquisition and expansion of these cells. The results showed that commonly measured serum biomarkers related to lipid levels, sex hormones, blood sugar homeostasis, inflammation and immune function, vitamins and minerals, kidney function, and liver function were associated with clonal expansion. The findings suggest that the mechanisms underlying these diseases may be related to clonal cell proliferation and expansion.

HUMAN MOLECULAR GENETICS (2023)

添加到收藏夹

Review Hematology

Clonal Hematopoiesis: Role in Hematologic and Non-Hematologic Malignancies

Ugo Testa, Germana Castelli, Elvira Pelosi

Summary: Hematopoietic stem cells (HSCs) ensure the coordinated and balanced production of all types of hematopoietic cells throughout life. Aging is associated with a gradual decline of HSCs' self-renewal and regenerative potential, leading to the development of clonal hematopoiesis. Clonal hematopoiesis of indeterminate potential (CHIP) refers to the clonal expansion of genetically variant hematopoietic cells with gene mutations and/or structural variants. CHIP increases exponentially with age and is linked to cancers, cardiovascular diseases, and other illnesses. The presence of CHIP significantly raises the risk of hematologic malignancy, especially in individuals with CHIP and peripheral blood cytopenia.

MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Oncology

Suspected Germline TP53 Variants and Clonal Hematopoiesis of Indeterminate Potential: Lessons Learned From a Molecular Tumor Board

Camila B. Xavier, Rudinei Link, Leonilia Abreu, Fabiana Bettoni, Fabiane Marson, Pedro A. F. Galante, Cibele Masotti, Mariane T. Amano, Vinicius de Molla, Anamaria A. Camargo, Paula F. Asprino, Jorge Sabbaga

Summary: This study reports a patient with a history of two primary cancers who harbored a likely pathogenic TP53 variant with low variant allele frequency in a blood sample. Such a result could have been misinterpreted as a Li-Fraumeni case, but other tests were conducted to elucidate the case.

ONCOLOGIST (2023)

添加到收藏夹

Review Biology

Obesity and Clonal Hematopoiesis of Indeterminate Potential: Allies in Cardiovascular Diseases and Malignancies

Luka Komic, Marko Kumric, Hrvoje Urlic, Azer Rizikalo, Marko Grahovac, Jelena Kelam, Marion Tomicic, Doris Rusic, Tina Ticinovic Kurir, Josko Bozic

Summary: The clonal hematopoiesis of indeterminate potential (CHIP) refers to the presence of detectable somatic mutations in genes associated with hematologic cancers in individuals without any apparent evidence of such conditions. Studies have shown that the frequently altered genes in CHIP are also associated with an increased risk of cardiovascular diseases, type 2 diabetes mellitus, myeloid malignancies, and obesity. The shared pathogenetic mechanisms of obesity and CHIP contribute to the development of these conditions.

LIFE-BASEL (2023)

添加到收藏夹

Article Hematology

Clonal Hematopoiesis of Indeterminate Potential Is Associated With Coronary Microvascular Dysfunction In Early Nonobstructive Coronary Artery Disease

Nadia Akhiyat, Terra Lasho, Morsaleh Ganji, Takumi Toya, Chang-Xin Shi, Xianfeng Chen, Esteban Braggio, Ali Ahmad, Michel T. Corban, Keith Stewart, Jenna Fernandez, Zhuoer Xie, Christy Finke, Lilach O. Lerman, Mrinal M. Patnaik, Amir Lerman

Summary: This study aims to investigate the relationship between clonal hematopoiesis (CH) and coronary microvascular dysfunction (CMD), as well as the risk for adverse cardiovascular outcomes. The study found that patients with CMD are more likely to have CH, and nearly one-third of major adverse cardiovascular events in CMD are mediated by CH.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Birth Weight Is Associated With Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Outcomes in Adulthood

Art Schuermans, Tetsushi Nakao, Yunfeng Ruan, Satoshi Koyama, Zhi Yu, Md Mesbah Uddin, Sara Haidermota, Whitney Hornsby, Adam J. Lewandowski, Alexander G. Bick, Abhishek Niroula, Siddhartha Jaiswal, Benjamin L. Ebert, Pradeep Natarajan, Michael C. Honigberg

Summary: This study found that higher birth weight is associated with an increased risk of developing clonal hematopoiesis of indeterminate potential (CHIP) in midlife, particularly DNMT3A CHIP. These findings provide valuable insights into the connections among early-life factors, CHIP, cancer, and cardiovascular disease.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

添加到收藏夹

Review Peripheral Vascular Disease

Clonal Hematopoiesis of Indeterminate Potential: an Expanding Genetic Cause of Cardiovascular Disease

Romit Bhattacharya, Alexander G. Bick

Summary: Clonal hematopoiesis of indeterminate potential (CHIP) is a novel cardiovascular risk factor associated with increased risk of leukemia and absolute risk of cardiovascular disease. The conditions and risk factors associated with CHIP are continuing to grow, while the mechanisms by which CHIP develops require further study.

CURRENT ATHEROSCLEROSIS REPORTS (2021)

添加到收藏夹

Article Hematology

Spectrum of hematological malignancies, clonal evolution and outcomes in 144 Mayo Clinic patients with germline predisposition syndromes

Emma St Martin, Alejandro Ferrer, Abhishek A. Mangaonkar, Shakila P. Khan, Mira A. Kohorst, Avni Y. Joshi, William J. Hogan, Horatiu Olteanu, Ann M. Moyer, Aref Al-Kali, Ayalew Tefferi, Dong Chen, Kitsada Wudhikarn, Ronald Go, David Viswanatha, Rong He, Rhett Ketterling, Phuong L. Nguyen, Jennifer L. Oliveira, Naseema Gangat, Terra Lasho, Mrinal M. Patnaik

Summary: Germline predisposition syndromes (GPS) are caused by constitutional abnormalities in tumor suppressive and homeostatic genes, leading to an increased risk of neoplasia in affected individuals. This study presented clinical and genomic data on 144 Mayo Clinic patients with GPS, revealing distinct patterns in different subtypes of GPS and the importance of comprehensive management approaches for patients with hematological neoplasms.

AMERICAN JOURNAL OF HEMATOLOGY (2021)

添加到收藏夹

Review Oncology

Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions

Inderpreet Singh, Abhay Singh

Summary: This article summarizes the current knowledge about clonal hematopoiesis of indeterminate potential (CHIP), its association with cardiovascular disease (CVD), and other outcomes, pathogenesis, postulated mechanisms of various pathologies, current knowledge gaps, possible targets of intervention, and therapeutic implications. Recently, CHIP has been identified as an independent risk factor for CVD and is associated with various other pathologies. CHIP is a clonal expansion of blood cells with leukemogenic mutations but without evidence of malignancy, and it is known to increase the inflammatory state and risk of CVD.

CURRENT ONCOLOGY REPORTS (2023)

添加到收藏夹

Correction Multidisciplinary Sciences

Inherited causes of clonal haematopoiesis in 97,691 whole genomes (vol 586, pg 763, 2020)

Alexander G. Bick, Joshua S. Weinstock, Satish K. Nandakumar, Charles P. Fulco, Erik L. Bao, Seyedeh M. Zekavat, Mindy D. Szeto, Xiaotian Liao, Matthew J. Leventhal, Joseph Nasser, Kyle Chang, Cecelia Laurie, Bala Bharathi Burugula, Christopher J. Gibson, Abhishek Niroula, Amy E. Lin, Margaret A. Taub, Francois Aguet, Kristin Ardlie, Braxton D. Mitchell, Kathleen C. Barnes, Arden Moscati, Myriam Fornage, Susan Redline, Bruce M. Psaty, Edwin K. Silverman, Scott T. Weiss, Nicholette D. Palmer, Ramachandran S. Vasan, Esteban G. Burchard, Sharon L. R. Kardia, Jiang He, Robert C. Kaplan, Nicholas L. Smith, Donna K. Arnett, David A. Schwartz, Adolfo Correa, Mariza de Andrade, Xiuqing Guo, Barbara A. Konkle, Brian Custer, Juan M. Peralta, Hongsheng Gui, Deborah A. Meyers, Stephen T. McGarvey, Ida Yii-Der Chen, M. Benjamin Shoemaker, Patricia A. Peyser, Jai G. Broome, Stephanie M. Gogarten, Fei Fei Wang, Quenna Wong, May E. Montasser, Michelle Daya, Eimear E. Kenny, Kari E. North, Lenore J. Launer, Brian E. Cade, Joshua C. Bis, Michael H. Cho, Jessica Lasky-Su, Donald W. Bowden, L. Adrienne Cupples, Angel C. Y. Mak, Lewis C. Becker, Jennifer A. Smith, Tanika N. Kelly, Stella Aslibekyan, Susan R. Heckbert, Hemant K. Tiwari, Ivana V. Yang, John A. Heit, Steven A. Lubitz, Jill M. Johnsen, Joanne E. Curran, Sally E. Wenzel, Daniel E. Weeks, Dabeeru C. Rao, Dawood Darbar, Jee-Young Moon, Russell P. Tracy, Erin J. Buth, Nicholas Rafaels, Ruth J. F. Loos, Peter Durda, Yongmei Liu, Lifang Hou, Jiwon Lee, Priyadarshini Kachroo, Barry I. Freedman, Daniel Levy, Lawrence F. Bielak, James E. Hixson, James S. Floyd, Eric A. Whitsel, Patrick T. Ellinor, Marguerite R. Irvin, Tasha E. Fingerlin, Laura M. Raffield, Sebastian M. Armasu, Marsha M. Wheeler, Ester C. Sabino, John Blangero, L. Keoki Williams, Bruce D. Levy, Wayne Huey-Herng Sheu, Dan M. Roden, Eric Boerwinkle, Joann E. Manson, Rasika A. Mathias, Pinkal Desai, Kent D. Taylor, Andrew D. Johnson, Paul L. Auer, Charles Kooperberg, Cathy C. Laurie, Thomas W. Blackwell, Albert V. Smith, Hongyu Zhao, Ethan Lange, Leslie Lange, Stephen S. Rich, Jerome I. Rotter, James G. Wilson, Paul Scheet, Jacob O. Kitzman, Eric S. Lander, Jesse M. Engreitz, Benjamin L. Ebert, Alexander P. Reiner, Siddhartha Jaiswal, Goncalo Abecasis, Vijay G. Sankaran, Sekar Kathiresan, Pradeep Natarajan

NATURE (2021)

添加到收藏夹

Review Genetics & Heredity

Germline risk of clonal haematopoiesis

Alexander J. Silver, Alexander G. Bick, Michael R. Savona

Summary: Clonal haematopoiesis (CH) is a common expansion of blood cell populations with somatic mutations associated with increased risks of malignancies, cardiovascular diseases, and mortality. The incidence of CH is shaped by inherited and environmental factors, sharing commonalities with genetic variations linked to age-related biomarkers and diseases. Recent research focuses on the genetic architecture of CH and its intersection with various diseases associated with aging.

NATURE REVIEWS GENETICS (2021)

添加到收藏夹

Correction Genetics & Heredity

Germline risk of clonal haematopoiesis (vol 13, pg 1, 2021)

Alexander J. Silver, Alexander G. Bick, Michael R. Savona

NATURE REVIEWS GENETICS (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease

Daniel H. Katz, Usman A. Tahir, Alexander G. Bick, Akhil Pampana, Debby Ngo, Mark D. Benson, Zhi Yu, Jeremy M. Robbins, Zsu-Zsu Chen, Daniel E. Cruz, Shuliang Deng, Laurie Farrell, Sumita Sinha, Alec A. Schmaier, Dongxiao Shen, Yan Gao, Michael E. Hall, Adolfo Correa, Russell P. Tracy, Peter Durda, Kent D. Taylor, Yongmei Liu, W. Craig Johnson, Xiuqing Guo, Jie Yao, Yii-Der Ida Chen, Ani W. Manichaikul, Deepti Jain, Claude Bouchard, Mark A. Sarzynski, Stephen S. Rich, Jerome I. Rotter, Thomas J. Wang, James G. Wilson, Pradeep Natarajan, Robert E. Gerszten

Summary: This study used whole genome sequencing to analyze the plasma proteome in individuals with greater African ancestry, identifying novel genetic determinants of cardiovascular diseases and uncovering new biological mechanisms specific to African ancestry.

CIRCULATION (2022)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Somatic Mutations in Cardiovascular Disease

J. Brett Heimlich, Alexander G. Bick

Summary: Advances in genomic sequencing have increased our understanding of the inherited basis of cardiovascular disease (CVD). Reanalysis of genomic datasets revealed somatically acquired DNA mutations as an unexpected risk factor for CVD. This review provides an overview of somatic mutations and their contributions to CVD, focusing on the most common manifestation of clonal hematopoiesis. The available data on how somatic mutations lead to tissue mosaicism in various forms of CVD are also reviewed, along with future research directions and technological advances.

CIRCULATION RESEARCH (2022)

添加到收藏夹

Article Clinical Neurology

Clonal Hematopoiesis Is Associated With Higher Risk of Stroke

Romit Bhattacharya, Seyedeh M. Zekavat, Jeffrey Haessler, Myriam Fornage, Laura Raffield, Md Mesbah Uddin, Alexander G. Bick, Abhishek Niroula, Bing Yu, Christopher Gibson, Gabriel Griffin, Alanna C. Morrison, Bruce M. Psaty, William T. Longstreth, Joshua C. Bis, Stephen S. Rich, Jerome Rotter, Russell P. Tracy, Adolfo Correa, Sudha Seshadri, Andrew Johnson, Jason M. Collins, Kathleen M. Hayden, Tracy E. Madsen, Christie M. Ballantyne, Siddhartha Jaiswal, Benjamin L. Ebert, Charles Kooperberg, JoAnn E. Manson, Eric A. Whitsel, Pradeep Natarajan, Alexander P. Reiner

Summary: Clonal hematopoiesis of indeterminate potential (CHIP) is associated with an increased risk of stroke, particularly with hemorrhagic and small vessel ischemic stroke.

STROKE (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Genetics of smoking and risk of clonal hematopoiesis

Michael G. Levin, Tetsushi Nakao, Seyedeh M. Zekavat, Satoshi Koyama, Alexander G. Bick, Abhishek Niroula, Benjamin Ebert, Scott M. Damrauer, Pradeep Natarajan

Summary: This study found strong associations between smoking and mosaic chromosomal alterations (mCAs) through observational study and Mendelian randomization analysis, but no association between smoking and clonal hematopoiesis of indeterminate potential (CHIP). This suggests that smoking may variably shape the fitness of clones bearing somatic mutations.

SCIENTIFIC REPORTS (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Mendelian randomization supports bidirectional causality between telomere length and clonal hematopoiesis of indeterminate potential

Tetsushi Nakao, Alexander G. Bick, Margaret A. Taub, Seyedeh M. Zekavat, Md M. Uddin, Abhishek Niroula, Cara L. Carty, John Lane, Michael C. Honigberg, Joshua S. Weinstock, Akhil Pampana, Christopher J. Gibson, Gabriel K. Griffin, Shoa L. Clarke, Romit Bhattacharya, Themistocles L. Assimes, Leslie S. Emery, Adrienne M. Stilp, Quenna Wong, Jai Broome, Cecelia A. Laurie, Alyna T. Khan, Albert Smith, Thomas W. Blackwell, Veryan Codd, Christopher P. Nelson, Zachary T. Yoneda, Juan M. Peralta, Donald W. Bowden, Marguerite R. Irvin, Meher Boorgula, Wei Zhao, Lisa R. Yanek, Kerri L. Wiggins, James E. Hixson, C. Charles Gu, Gina M. Peloso, Dan M. Roden, Muagututi'a S. Reupena, Chii-Min Hwu, Dawn L. DeMeo, Kari E. North, Shannon Kelly, Solomon K. Musani, Joshua C. Bis, Donald M. Lloyd-Jones, Jill M. Johnsen, Michael Preuss, Russell P. Tracy, Patricia A. Peyser, Dandi Qiao, Pinkal Desai, Joanne E. Curran, Barry Freedman, Hemant K. Tiwari, Sameer Chavan, Jennifer A. Smith, Nicholas L. Smith, Tanika N. Kelly, Bertha Hidalgo, L. Adrienne Cupples, Daniel E. Weeks, Nicola L. Hawley, Ryan L. Minster, Ranjan Deka, Take T. Naseri, Lisa de Las Fuentes, Laura M. Raffield, Alanna C. Morrison, Paul S. Vries, Christie M. Ballantyne, Eimear E. Kenny, Stephen S. Rich, Eric A. Whitsel, Michael H. Cho, M. Benjamin Shoemaker, Betty S. Pace, John Blangero, Nicholette D. Palmer, Braxton D. Mitchell, Alan R. Shuldiner, Kathleen C. Barnes, Susan Redline, Sharon L. R. Kardia, Goncalo R. Abecasis, Lewis C. Becker, Susan R. Heckbert, Jiang He, Wendy Post, Donna K. Arnett, Ramachandran S. Vasan, Dawood Darbar, Scott T. Weiss, Stephen T. McGarvey, Mariza de Andrade, Yii-Der Ida Chen, Robert C. Kaplan, Deborah A. Meyers, Brian S. Custer, Adolfo Correa, Bruce M. Psaty, Myriam Fornage, JoAnn E. Manson, Eric Boerwinkle, Barbara A. Konkle, Ruth J. F. Loos, Jerome Rotter, Edwin K. Silverman, Charles Kooperberg, John Danesh, Nilesh J. Samani, Siddhartha Jaiswal, Peter Libby, Patrick T. Ellinor, Nathan Pankratz, Benjamin L. Ebert, Alexander P. Reiner, Rasika A. Mathias, Ron Do, Pradeep Natarajan

Summary: This study investigated the relationship between CHIP, LTL, and CAD using data from the Trans-Omics for Precision Medicine (TOPMed) program and UK Biobank. The results showed that genetically imputed longer LTL increased the risk of developing CHIP, which then hastened the shortening of measured LTL. There was also evidence of mediation between CHIP and CAD through LTL.

SCIENCE ADVANCES (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Whole Genome Association Study of the Plasma Metabolome Identifies Metabolites Linked to Cardiometabolic Disease in Black Individuals

Usman A. Tahir, Daniel H. Katz, Julian Avila-Pachecho, Alexander G. Bick, Akhil Pampana, Jeremy M. Robbins, Zhi Yu, Zsu-Zsu Chen, Mark D. Benson, Daniel E. Cruz, Debby Ngo, Shuliang Deng, Xu Shi, Shuning Zheng, Aaron S. Eisman, Laurie Farrell, Michael E. Hall, Adolfo Correa, Russell P. Tracy, Peter Durda, Kent D. Taylor, Yongmei Liu, W. Craig Johnson, Xiuqing Guo, Jie Yao, Yii-Der Ida Chen, Ani W. Manichaikul, Frederick L. Ruberg, William S. Blaner, Deepti Jain, Claude Bouchard, Mark A. Sarzynski, Stephen S. Rich, Jerome Rotter, Thomas J. Wang, James G. Wilson, Clary B. Clish, Pradeep Natarajan, Robert E. Gerszten

Summary: Integrating genetic information with metabolomics provides new insights into genes affecting human metabolism. This study integrates genomic and metabolomic data in Black individuals, highlighting the value of whole genome sequencing in diverse populations and linking circulating metabolites to human disease.

NATURE COMMUNICATIONS (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Proteomic profiling platforms head to head: Leveraging genetics and clinical traits to compare aptamer- and antibody-based methods

Daniel H. Katz, Jeremy M. Robbins, Shuliang Deng, Usman A. Tahir, Alexander G. Bick, Akhil Pampana, Zhi Yu, Debby Ngo, Mark D. Benson, Zsu-Zsu Chen, Daniel E. Cruz, Dongxiao Shen, Yan Gao, Claude Bouchard, Mark A. Sarzynski, Adolfo Correa, Pradeep Natarajan, James G. Wilson, Robert E. Gerszten

Summary: This study compared the performance of three proteomic profiling techniques, SomaScan1.3K, SomaScan5K, and Olink Explore, in terms of precision, accuracy, analytic breadth, and phenotypic associations. The results showed that Olink platform had more reliable protein target specificity and a higher number of phenotypic associations, while Soma platforms had greater measurement precision and analytic breadth across the proteome.

SCIENCE ADVANCES (2022)

添加到收藏夹

Letter Cardiac & Cardiovascular Systems

Interleukin-6 Receptor Polymorphism Attenuates Clonal Hematopoiesis-Mediated Coronary Artery Disease Risk Among 451 180 Individuals in the UK Biobank

Caitlyn Vlasschaert, J. Brett Heimlich, Michael J. Rauh, Pradeep Natarajan, Alexander G. Bick

CIRCULATION (2023)

添加到收藏夹

Review Oncology

Lymphoid clonal hematopoiesis: implications for malignancy, immunity, and treatment

Kelly von Beck, Troy von Beck, P. Brent Ferrell Jr, Alexander G. Bick, Ashwin Kishtagari

Summary: Clonal hematopoiesis (CH) is the expansion of hematopoietic stem cell clones due to acquired somatic mutations or mosaic chromosomal alterations. While somatic mutations are associated with myeloid malignancies, a recent study discovered a subset of mutations and chromosomal alterations that are specifically associated with lymphoid malignancies, termed lymphoid clonal hematopoiesis (L-CH). Unlike myeloid clonal hematopoiesis, L-CH can originate from both stem cells and differentiated progeny stages. This review explores the definition of L-CH in the context of lymphocyte maturation and lymphoid malignancy precursor disorders, its association with late-onset autoimmunity and immunodeficiency, as well as therapy-related L-CH following chemotherapy or hematopoietic stem cell transplantation.

BLOOD CANCER JOURNAL (2023)

添加到收藏夹

Article Oncology

Clonal Hematopoiesis in Young Women Treated for Breast Cancer

Christopher J. Gibson, Geoffrey Fell, Tal Sella, Adam S. Sperling, Craig Snow, Shoshana M. Rosenberg, Greg Kirkner, Ashka Patel, Deborah Dillon, Alexander G. Bick, Donna Neuberg, Ann H. Partridge, Peter G. Miller

Summary: This study aimed to investigate the presence of clonal hematopoiesis of indeterminate potential (CHIP) in young women treated for breast cancer and its impact on prognosis. The results showed that only a small number of patients had clones large enough to be diagnosed as CHIP, and there was no significant association between their prognosis and non-breast cancer-related outcomes.

CLINICAL CANCER RESEARCH (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Birth Weight Is Associated With Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Outcomes in Adulthood

Art Schuermans, Tetsushi Nakao, Yunfeng Ruan, Satoshi Koyama, Zhi Yu, Md Mesbah Uddin, Sara Haidermota, Whitney Hornsby, Adam J. Lewandowski, Alexander G. Bick, Abhishek Niroula, Siddhartha Jaiswal, Benjamin L. Ebert, Pradeep Natarajan, Michael C. Honigberg

Summary: This study found that higher birth weight is associated with an increased risk of developing clonal hematopoiesis of indeterminate potential (CHIP) in midlife, particularly DNMT3A CHIP. These findings provide valuable insights into the connections among early-life factors, CHIP, cancer, and cardiovascular disease.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.